Anteo Diagnostics Ltd Signs Patent And Technology License Agreement With eBioscience

Anteo Diagnostics Ltd announced that it has signed a Patent and Technology License Agreement with eBioscience, life sciences company, providing them with access to the Company’s Mix&Go technology. Under the terms of the agreement, Anteo will supply Mix&Go for use in the manufacture of biological reagents for all applicable markets in which the Company operates. Anteo will receive an initial upfront payment, fixed revenue for Mix&Go reagent supplied, and a royalty fee paid quarterly based on a percentage of worldwide net sales. eBioscience has undertaken technical assessment of the Mix&Go technology, performed due diligence and reached an agreement with great efficiency. The outcome could only occur with goodwill from both parties. Further, Anteo expects to be working in close collaboration with eBioscience into the future to ensure that all products that incorporate Mix&Go are delivered to the market promptly, that the technology is used across the eBioscience product range and that where applicable, Mix&Go is used in new products.

—–

To view the full article, please click here.